Inhaled heparin significantly lowers the risk of death and ventilation in COVID-19 patients while also showing potential against other respiratory infections. With its unique triple-action benefits, it could serve as a powerful and accessible treatment worldw…
A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National… [+2658 chars]
Read more: https://www.sciencedaily.com/releases/2025/09/250928095616.htm
Source: Science Daily